Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

The Swiss biotech company Roche on Monday announced plans for a $550 million expansion of its Indianapolis diagnostics and ...

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

Roche plans to invest over $700 million in setting up a new plant in North Carolina and up to $550 million in expanding its Indianapolis diagnostics hub.

Dr Ray O’Connor continues his look at the latest clinical articles on the importance of lifestyle advice in doctor-patient ...